Gender Disparities in Cardiovascular Disease and Their Management: A Review
- PMID: 38836150
- PMCID: PMC11148660
- DOI: 10.7759/cureus.59663
Gender Disparities in Cardiovascular Disease and Their Management: A Review
Abstract
Worldwide, cardiovascular diseases (CVDs) are still the primary cause of death, and there are notable differences between sexes when it comes to symptoms/course and treatment. Due to evolving healthcare technologies, significant progress has been made in understanding CVDs. Hence, it is evident that gender disparities exist in the clinical presentation, prevalence, management, outcomes, and risk factors, including biological, behavioral, and sociocultural factors. This narrative review is designed to provide a generalized idea of gender disparities in CVDs. It aims to provide insights to prove the role of hormonal influences, genetic predispositions, and the difference in physiological outcomes owing to different genders. This review explores subtle distinctions in CVD across genders, including changes in structure, biology, and hormones that affect how illness presents and progresses. Lifestyle variables also influence sociocultural factors and gender disparities in risk profiles. Traditional risk factors, diabetes mellitus (DM), cholesterol levels, and smoking may have different weights and relevance in men and women. Moreover, age and other conventional risk variables have distinct effects on gender. Treatment efficacy may be impacted by the expression of gender-specific factors, emphasizing the necessity for customized strategies. Development of CVDs can be delayed or prevented, and its consequences can be lessened with the early identification and effective management of gender-specific factors. More investigation is necessary to clarify complex interactions between structural, biochemical, and hormonal aspects across genders in order to maximize treatment results and reduce the burden of CVDs.
Keywords: add-on pharmacotherapy; cardiology corner; ecg abnormalities; gender role; health aging.
Copyright © 2024, Betai et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Sex/Gender-Specific Imbalance in CVD: Could Physical Activity Help to Improve Clinical Outcome Targeting CVD Molecular Mechanisms in Women?Int J Mol Sci. 2020 Feb 21;21(4):1477. doi: 10.3390/ijms21041477. Int J Mol Sci. 2020. PMID: 32098263 Free PMC article. Review.
-
Gender determinants of cardiovascular risk factors and diseases.J Cardiovasc Med (Hagerstown). 2010 Mar;11(3):207-20. doi: 10.2459/JCM.0b013e32833178ed. J Cardiovasc Med (Hagerstown). 2010. PMID: 19829128
-
RNA-seq driven expression and enrichment analysis to investigate CVD genes with associated phenotypes among high-risk heart failure patients.Hum Genomics. 2021 Nov 13;15(1):67. doi: 10.1186/s40246-021-00367-8. Hum Genomics. 2021. PMID: 34774109 Free PMC article.
-
Reprint of: Proteomics in cardiovascular diseases: Unveiling sex and gender differences in the era of precision medicine.J Proteomics. 2018 Apr 30;178:57-72. doi: 10.1016/j.jprot.2018.03.017. Epub 2018 Apr 3. J Proteomics. 2018. PMID: 29622522 Review.
-
Epidemiology and demographic patterns of cardiovascular diseases and neoplasms deaths in Western Europe: a 1990-2019 analysis.Public Health. 2024 Jun;231:187-197. doi: 10.1016/j.puhe.2024.04.003. Epub 2024 May 3. Public Health. 2024. PMID: 38703493
Cited by
-
Gender-Specific Population Attributable Fractions for Cardiovascular Disease and All-Cause Mortality Associated with Living Arrangement in Community-Dwelling Older People.J Gen Intern Med. 2025 Jun 25. doi: 10.1007/s11606-025-09648-7. Online ahead of print. J Gen Intern Med. 2025. PMID: 40562890
-
Exploring sex-based differences in patient outcomes: A secondary analysis of Heartwatch, an Irish cardiovascular secondary prevention programme.Int J Cardiol Cardiovasc Risk Prev. 2025 Feb 14;24:200376. doi: 10.1016/j.ijcrp.2025.200376. eCollection 2025 Mar. Int J Cardiol Cardiovasc Risk Prev. 2025. PMID: 40094086 Free PMC article.
-
Racial and ethnic differences in cardiometabolic predictors of white matter hyperintensities burden among males: The HABS-HD study.J Alzheimers Dis. 2025 Aug 4:13872877251365128. doi: 10.1177/13872877251365128. Online ahead of print. J Alzheimers Dis. 2025. PMID: 40760862 Free PMC article.
-
Prevalence and Hospitalization Trends of Cardiovascular Disease in Diabetic Populations: An Analysis of the United States Diabetes Surveillance System (USDSS) Data From 2000 to 2022.Cureus. 2025 Jul 14;17(7):e87886. doi: 10.7759/cureus.87886. eCollection 2025 Jul. Cureus. 2025. PMID: 40821258 Free PMC article.
-
Development and validation of a five-year cardiovascular risk assessment tool for Asian adults aged 75 years and older.BMC Geriatr. 2025 Jan 8;25(1):15. doi: 10.1186/s12877-024-05660-4. BMC Geriatr. 2025. PMID: 39780086 Free PMC article.
References
-
- WHO: cardiovascular diseases. [ Jun; 2021 ]. 2021. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases... https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases...
-
- Anand S, Srinath RK, Prabhakaran D. CRC Press; 2023. Public Health Approach to Cardiovascular Disease Prevention & Management.
-
- Campbell KR. Women and Cardiovascular Disease : Addressing Disparities in ColleCare. World Scientific; [ Feb; 2023 ]. 2015. Women and cardiovascular disease: addressing disparities in care.
-
- Sex-related differences in plaque characteristics and endothelial shear stress related plaque-progression in human coronary arteries. Wentzel JJ, Papafaklis MI, Antoniadis AP, et al. Atherosclerosis. 2022;342:9–18. - PubMed
-
- Sex and gender differences in cardiovascular drug therapy. Seeland U, Regitz-Zagrosek V. Handb Exp Pharmacol. 2012:211–236. - PubMed
Publication types
LinkOut - more resources
Full Text Sources